Resources
-
Challenges in Getting Genome Editing Medicines into the Clinic
Speaker Presentation: CGTP 2025
Ramsey Phillip, Sangamo Therapuetics, Inc., 2025 -
Transparency-Driven Partnerships for Shared Success – iPSC Journey
Speaker Presentation: CGTP 2025
Pedro Castanho Vaz, Catalent, 2025 -
Developing and Deploying N-of-1 Gene-Editing Therapies
Speaker Presentation: CGTP 2025
Musunuru Kiran, University of Pennsylvania, 2025 -
Investigating the Aggregation, Genome Release, and Self-Interactions of Adeno-Associated Virus Formulations
Speaker Presentation: CGTP 2025
Motabar Lily, University of Delaware, 2025 -
Considerations in Development, Characterization, and Commercialization of Platform Processes
Speaker Presentation: CGTP 2025
Madaras Stephen, Miltenyi Biotec, 2025 -
A Single, Ready-to-Use Kit for Fast, Comprehensive Analysis of Both Plasmid Topological Isoforms and Linear Sizing on a Multi-Capillary Electrophoresis Platform
Speaker Presentation: CGTP 2025
Li Tingting, SCIEX, Kang Henry, SCIEX, 2025 -
Healthy Donor Cells Compared to SCD and TDT Patient Cells in Casgevy Process: Performance and Product Quality
Speaker Presentation: CGTP 2025
Kadiyala Irina, Vertex Pharmaceuticals Incorporated, 2025 -
ATMP Activities at MEB
Speaker Presentation: CGTP 2025
Hoefnagel Marcel, Medicines Evaluation Board, 2025 -
INS1203: RNA-End Joining Technology Enables A Dual AAV Approach for ABCA4 Gene Replacement in Stargardt Disease
Speaker Presentation: CGTP 2025
Hilde Kathryn, Insmed Incorporated, 2025 -
Lipid Nanoparticles-Points to Consider For Non-Viral Delivery of RNA-based Therapeutics
Speaker Presentation: CGTP 2025
Heidaran Mo, Cellx Consulting, 2025 -
Optimizing Analytical Release Testing Through Reduced Volume and Turn-around Times
Speaker Presentation: CGTP 2025
Giffin Michael, ElevateBio, 2025 -
Anticipating the
Exceptional Release
Bottleneck
Speaker Presentation: CGTP 2025
Eisenstatt Jessica, AstraZeneca, Preville Yoonji, AstraZeneca, 2025 -
Integrating Process and Analytics: A Prerequisite to Streamlining the Production of Viral Vectors
Speaker Presentation: CGTP 2025
Deb Amitabha, CellGene Consulting LLC, 2025 -
CRISPR Genome Editing Components Used for Ex-Vivo Genome-Editing of Allogeneic Cell Therapy Products: Their Clearance and Their Effects
Speaker Presentation: CGTP 2025
Chialastri Alex, Century Therapeutics, 2025 -
Beyond “One Disease at a Time” : Genetic Therapy Platforms for Rare Monogenic Disease
Speaker Presentation: CGTP 2025
Brooks Philip J., NIH, 2025 -
Recent Regulatory Advancements on Cell and Gene Therapy Products in Japan
Speaker Presentation: CGTP 2025
Atsushi Nishikawa, PMDA, 2025 -
CGTP 2025 Scientific Program
Scientific Program: CGTP 2025
-
CGTP Summit 2025 Summary Infographic
Summary Infographic: CGTP Summit 2025
-
Advancing Genomic Medicine: Navigating Challenges in CMC Potency Assay Development Throughout the Product Life-Cycle
Speaker Presentation: CGTP Summit 2025
Nair Savita, Ramsey Phillip, Sangamo Therapeutics, Inc., 2025 -
Session I Introductory Slides from Co-chairs
Speaker Presentation: CGTP Summit 2025
Gianelli Francois, TreeFrog Therapeutics, Peters Elaine, 2025